Bern University Hospital, Inselspital
Bern, 3010, Switzerland
NCT Number: NCT04585854
The purpose of this study is to investigate the impact of caffeine on myocardial oxygenation and other cardiovascular magnetic resonance parameters in healthy controls.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Bern, 3010, Switzerland
Caffeine is presumed to create a confounder with diagnostic imaging. The vasodilatory capacity is considered a key measure for the detection of significant coronary disease with stenosed epicardial arterial conduit vessels and overall microvascular function, including endothelial dysfunction. Twenty nine healthy controls will undergo a baseline cardiovascular magnetic resonance (CMR) exam. Afterwards, participants will consume coffee in the presence of study personnel. This will consist of 3 espresso shots, which will be consumed within 15 minutes. Approximately 2h after coffee consumption the CMR exam will be repeated. The goal will be to investigate the impact of caffeine on myocardial features. In particular the effect on the myocardial oxygenation response to vasodilating and vasoconstricting stimuli.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Consumption of 3 shots of espresso
Other names: Coffee
Time frame: Through study completion up to 5 hours, before and after caffeine
Percent (%) Measure of oxygenation-sensitive signal change measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Percent (%), measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
L/min/m2, measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Percent (%), a measure of systolic function (shortening and thickening) of the myocardium measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Milliseconds (ms), measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Change in strain over time (/second), measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Milliseconds (ms), measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Percent, measured by CMR
Time frame: Through study completion up to 5 hours, before and after caffeine
Blood pressure * heart rate
Insel Gruppe AG, University Hospital Bern
Other
Acronym: Coffee-O2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07711665
Caffeine, Placebo - Control
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT07711652
Caffeine, Placebo
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT07333443
Caffeine, Climbing
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT07386899
Caffeine
Izmir, Bornova, Turkey (Türkiye)
View Trial Details